NATURAL PRODUCT RESEARCH AND DEVELOPMENT ›› 2020, Vol. 32 ›› Issue (12): 2101-2108. doi: 10.16333/j.1001-6880.2020.12.015

Previous Articles     Next Articles

The research of EGCG combined with cisplatin in inhibiting the proliferation,invasion and migration of osteosarcoma MG-63 cells

HUANG Lei1,2,ZOU Ri-chang3,SONG Jia-qi1,LUO Chao1,2,YIN Chang-chang4*   

  1. 1Graduate School of Medicine,Nanchang University;2The Second Hospital Affiliated of Nanchang University,Nanchang 330006,China;
    3Fuzhou Municipal Hospital,Fuzhou 344000,China;4Basic Medical College of Jiujiang University,Jiujiang 332000,China

  • Online:2020-12-28 Published:2020-12-24

Abstract:

To investigate the effect of epigallocatechin gallate (EGCG) combined with cisplatin on cell proliferation of human osteosarcoma MG-63 cells and its possible mechanism.MG-63 cells were treated with different concentrations of EGCG and cisplatin alone or in combination.The cell growth inhibition rate was measured by CCK-8 morphology was observed by microscope,the Transwell chamber detects the number of cell invasions,and the scratch test detects the cell migration ability;Western blot detection of Bax,Bcl-2,Bcl-xL,MMP-2,MMP-9,Caspase-3 and cleaved Caspase-3.The results showed that the ability of proliferation,invasion and migration of MG-63 cells decreased with the increase of the dose of EGCG and cisplatin (P<0.05),and the combined drug inhibition was stronger;the expression levels of Bcl-2,Bcl-xL,MMP-2 and MMP-9 were significantly down-regulated (P<0.05),and the levels of Bax,Caspase-3 and cleaved Caspase-3 were significantly up-regulated(P<0.05);Compared with the gallic acid catechin gallate group and the monotherapy application of the platinum group,the MG-63 cells in the combination group had the highest inhibition rate,and the related protein expression was also more significant.To sum up,EGCG can effectively inhibit the proliferation of human osteosarcoma MG-63 cells and induce apoptosis.The effect is more obvious when combined with cisplatin.

Key words: EGCG, cisplatin, osteosarcoma, drug combination, cell proliferation

CLC Number: